StockData

Nutex Health Inc. (NUTX) bonds

NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3069% below fair value
$173.67+2.26 (+1.32%)

Close on Nov 13, 2026Market cap $1.19BP/E 7.4Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$42.30M
$8.10M due within a year
Net debt
-$207.61M
After $249.91M of cash
Implied interest rate
56.01%
FY2025 interest ÷ average debt
Interest coverage
12.4×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Nutex Health's 10-Q for the period ended Jun 30, 2026

IssueCarrying value
Deferred payment$1.00M
Line of credit secured by all assets$98.00K
Seller note$5.80M
Term loan secured by deposits$0
Term loans of Real Estate VIEs$9.92M
Term loans secured by all assets$18.26M
Term loans secured by property and equipment$4.82M
Unsecured convertible term notes
Convertible at $60 a share
$0

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Standby Letters of Credit$1.70M

See a number that looks wrong?